Statistics

Total Visits

Views
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 176

Total Visits per Month

November 2014 December 2014 January 2015 February 2015 March 2015 April 2015 May 2015
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 9 1 3 4 1 0 1

File Downloads

Views
ijo_34_4_1155_PDF published.pdf 57

Top Country Views

Views
United States 42
Germany 20
Canada 18
China 17
Sweden 12
France 10
United Kingdom 9
South Korea 5
Russia 5
India 2

Top City Views

Views
Miami Beach 17
Toronto 13
Nynäs 9
Beijing 7
Kansas City 5
Zhengzhou 5
Seoul 3
Ottawa 2
Bangalore 1
Cambridge 1